Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus
Identifieur interne : 003D53 ( Ncbi/Curation ); précédent : 003D52; suivant : 003D54Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus
Auteurs : Chih-Jung Kuo ; Po-Huang LiangSource :
- ChemBioEng Reviews [ 2196-9744 ] ; 2015.
Abstract
The main protease of SARS‐associated coronavirus (SARS‐CoV), also called 3C‐like protease (3CLpro), is vital for the viral replication. It cleaves the replicase polyproteins at 11 sites and is a promising drug target. Several groups of inhibitors have been identified through high‐throughput screening and rational drug design. In addition to the pharmaceutical applications, a mutant 3CLpro (T25G) with an expanded S1′ space has been demonstrated to tolerate larger residues at P1′, facilitating the cleavage behind the recognition sequence. This review summarizes current developments in anti‐SARS agents targeting 3CLpro and the application of the mutant protease as a tag‐cleavage endopeptidase.
Url:
DOI: 10.1002/cben.201400031
PubMed: NONE
PubMed Central: 7159133
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001673
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :001673
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000816
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003D53
Links to Exploration step
PMC:7159133Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus</title>
<author><name sortKey="Kuo, Chih Ung" sort="Kuo, Chih Ung" uniqKey="Kuo C" first="Chih-Jung" last="Kuo">Chih-Jung Kuo</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Liang, Po Uang" sort="Liang, Po Uang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7159133</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159133</idno>
<idno type="RBID">PMC:7159133</idno>
<idno type="doi">10.1002/cben.201400031</idno>
<idno type="pmid">NONE</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">001673</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001673</idno>
<idno type="wicri:Area/Pmc/Curation">001673</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001673</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000816</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000816</idno>
<idno type="wicri:Area/Ncbi/Merge">003D53</idno>
<idno type="wicri:Area/Ncbi/Curation">003D53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus</title>
<author><name sortKey="Kuo, Chih Ung" sort="Kuo, Chih Ung" uniqKey="Kuo C" first="Chih-Jung" last="Kuo">Chih-Jung Kuo</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Liang, Po Uang" sort="Liang, Po Uang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">ChemBioEng Reviews</title>
<idno type="eISSN">2196-9744</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Abstract</title>
<p>The main protease of SARS‐associated coronavirus (SARS‐CoV), also called 3C‐like protease (3CL<sup>pro</sup>
), is vital for the viral replication. It cleaves the replicase polyproteins at 11 sites and is a promising drug target. Several groups of inhibitors have been identified through high‐throughput screening and rational drug design. In addition to the pharmaceutical applications, a mutant 3CL<sup>pro</sup>
(T25G) with an expanded S1′ space has been demonstrated to tolerate larger residues at P1′, facilitating the cleavage behind the recognition sequence. This review summarizes current developments in anti‐SARS agents targeting 3CL<sup>pro</sup>
and the application of the mutant protease as a tag‐cleavage endopeptidase.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003D53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:7159133 |texte= Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |